Table 4.

Changes of immune parameters from the beginning of the study to the last follow-up

VariableMultitargetIVCYDifference (95% CI)P
Negative conversion ratio of Anti-dsDNA6/12 (50.0%)4/12 (33.3%)16.7% (−22.2% to 55.5%)0.680
Normalization rate of serum C311/20 (55.0%)8/19 (42.1%)12.9% (−18.2% to 44.0%)0.527